Amgen Inc.(AMGN) Q3
EPS: 6.45 USD; Forecast 5.79 USD
Revenue: 10.37B USD; Forecast 10.07B USD
Reporting period: 2026 Q3 (period ended 2026-09-30)
Release date: 2026-11-03